Search Results 1951-1960 of 13628 for monoclonal antibody

1. Multiple myeloma - Doctors and departments - Mayo Clinic

   Amyloidosis, Multiple myeloma, Monoclonal gammopathy of undetermined significance ... Bispecific antibody therapy · Bone marrow transplant · Cancer treatment ...

2. Study to Evaluate Serial Amnioinfusions as Therapy for Pulmonary Hypoplasia in Fetuses with Renal Failure or Severe Renal Anomalies - Mayo Clinic

   ... antibody and an alkylating agent. DLBCL cohort: patients with DLBCL that has relapsed after or is refractory to at least 2 prior lines of systemic therapy ...

3. Cabozantinib And Nivolumab In Treating Patients With Advanced, Recurrent Or Metastatic Endometrial Cancer - Mayo Clinic

   ... antibodies) or radiotherapy within 4 weeks ... Patients should be excluded if they have had prior treatment with anti-CTLA-4 antibody or any other antibody ...

4. Risk Factors Associated with Clustered Plasma Cell Dyscrasias in Minnesota - Mayo Clinic

   Confirmed diagnosis of multiple myeloma (MM), Waldenstrom macroglobulinemia (WM) or monoclonal gammopathy of undetermined significance (MGUS); Agreement in ...

5. Open-label Study Of The Safety And Activity Of Oprozomib In Patients With Hematologic Malignancies - Mayo Clinic

   ... antibody therapy. Radiation therapy within 3 weeks prior to first dose. Radioimmunotherapy within 8 weeks prior to first dose. Localized radiation therapy ...

6. Study Of Pomalidomide And Low Dose Dexamethasone With Or Without Pembrolizumab (MK-3475) In Refractory Or Relapsed And Refractory Multiple Myeloma (RrMM) (MK-3475-183/KEYNOTE-183) - Mayo Clinic

   ... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell costimulation or checkpoint pathways); Is pregnant or breast ...

7. Multiple myeloma - Doctors and departments - Mayo Clinic

   Bispecific antibody therapy · Bone marrow transplant · Cancer treatment · CAR-T cell therapy · Chemotherapy · Complete blood count (CBC) · Creatinine test · CT ...

8. Hematology - Clinical trials

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

9. A Study Of Ruxolitinib For The Treatment Of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

   At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...

10. Cabozantinib-S-Malate In Treating Younger Patients With Recurrent, Refractory, Or Newly Diagnosed Sarcomas, Wilms Tumor, Or Other Rare Tumors - Mayo Clinic

    Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to Grade ≤ 1.